Richmond Pharmacology is pleased to attend the ESC Heart Failure Congress in Barcelona, Spain, on 09 -12 May 2026.

This leading event brings together cardiology experts, researchers, and industry innovators to advance heart failure care through cutting-edge science, clinical insights, and collaborative solutions.

Representing Richmond Pharmacology

  • Jörg Taubel, Chief Executive Officer

We look forward to connecting with attendees to discuss Richmond’s expertise in:

  • Innovations in heart failure drug development
  • Clinical trial design for complex cardiac conditions
  • Regulatory pathways for novel therapies
  • Patient-centric approaches and recruitment strategies
  • Collaboration between academia, industry, and regulators

Connect With Us

If you are attending ESC Heart Failure 2026 and would like to explore partnership or development opportunities email us at:

📧 fasteranswers@richmondpharmacology.com

Latest news

Richmond Pharmacology Appoints Adam Hurd as Operations Director

August 17, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Adam Hurd as Operations Director
Read more

Upcoming Event

Women's Health Horizons 2026

22 September 2026
Richmond Pharmacology is pleased to join the Women’s Health Horizons London Summit hosted by the Royal College of Obstetricians and Gynaecologists in London, 22 September 2026
View event